Condition

Advanced CCNE1-amplified Solid Tumors clinical trials and research

• 2Clinical trials
• 16Countries

All recruiting trials (2)

• GVV858 alone or with fulvestrant or letrozole for HR+/HER2- breast cancer and other advanced tumors

  This trial tests whether GVV858 alone or with fulvestrant or letrozole can help adults with HR+/HER2- advanced breast cancer, CCNE1‑amplified solid tumors, or metastatic castration‑resistant prostate cancer.

  Recruiting at 16 sites Phase 1/2 Novartis · Atlanta, Georgia and 15 other locations · NCT07288359

• Treatment for advanced HR+/HER2- breast cancer and other solid tumors

  This study is testing a new treatment called ECI830, alone and with other medications, to see if it helps people with advanced hormone receptor-positive breast cancer and certain other solid tumors.

  Recruiting at 33 sites Phase 1/2 Novartis · Los Angeles, California and 32 other locations · NCT06726148

Related topics

Quick answers

How many Advanced CCNE1-amplified Solid Tumors clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 16 countries. The most sites are in Canada (2 trials), Czechia (2 trials), Denmark (2 trials), France (2 trials), Germany (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →